Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E. Ware, Robert J. Adams, Isaac Odame et al.|The Lancet|2015Cited by 518
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell AnemiaRussell E. Ware, Robert J. Adams, Barry R. Davis et al.|Blood|2015Cited by 17
Use of Electron Microscopy and Other Special Techniques in the Investigation of Suspected Specimen ContaminationCraig W. Zuppan, Gary W. Mierau, Douglas A. Weeks et al.|Ultrastructural Pathology|1997Cited by 1